Is endovascular aneurysm repair in nonagenarians safe and effective?
This is the largest reported EVAR series in nonagenarians. Despite their advanced age, these patients benefit from EVAR with low morbidity, low mortality, and mean survival exceeding 2.4 years. Survival appears best in those patients with ≤5 comorbidities. With or without symptoms, patients over the age of 90 should be considered for EVAR.
Antiseptic-coated catheters appear to be clinically effective and economically efficient in a real-world setting.